Prestige Consumer Healthcare Inc. (PBH) Guidance & Earnings Results
On 2026-08-06 Prestige Consumer Healthcare Inc. raised guidance: "Revenue raised from $1,100-$1,121M to $1,290-$1,315M; Adjusted Diluted EPS raised from $4.42-$4.51 to…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PBHPrestige Consumer Healthcare Inc.Follow PBH — free
—
Price chart with a free account
- Market cap
- 2.3B
- P/E TTM
- 13.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 6 Aug 26 | Raised | Revenue raised from $1,100-$1,121M to $1,290-$1,315M; Adjusted Diluted EPS raised from $4.42-$4.51 to $4.55-$4.65 · full year |
| 13 May 26 | Raised | Organic revenue growth and adjusted diluted EPS growth of 1% to 3% |
| 5 Feb 26 | Reaffirmed | FY2026 net sales outlook narrowed to ~$1.1B · full year |
| 6 Nov 25 | Raised | FY2026 adjusted diluted EPS $4.54-$4.58 (high end of previous range); free cash flow $245M+ · full year |
| 7 Aug 25 | Lowered | FY26 revenue $1,100-1,115M from $1,140-1,155M; FY26 diluted EPS $4.50-4.58 from prior; free cash flow $245M+ unchanged · full year |
Prestige Consumer Healthcare Inc. — questions
- What guidance did Prestige Consumer Healthcare Inc. give?
- On 2026-08-06: "Revenue raised from $1,100-$1,121M to $1,290-$1,315M; Adjusted Diluted EPS raised from $4.42-$4.51 to $4.55-$4.65"
- When does Prestige Consumer Healthcare Inc. report earnings?
- Prestige Consumer Healthcare Inc.'s next earnings report is expected on 2026-11-05.
Every figure on this page comes from Prestige Consumer Healthcare Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.